Registered number
08783030
Cambridge Neurotech Limited
Filleted Accounts
30 November 2024
Cambridge Neurotech Limited
Registered number: 08783030
Balance Sheet
as at 30 November 2024
Notes 2024 2023
£ £ £ £
Fixed assets
Tangible assets 3 7,695 11,070
Current assets
Stocks 24,498 24,396
Debtors 4 757,070 807,506
Investments held as current assets 5 248,998 -
Cash at bank and in hand 1,439,192 1,507,691
2,469,758 2,339,593
Creditors: amounts falling due within one year 6 (120,170) (231,129)
Net current assets 2,349,588 2,108,464
Net assets 2,357,283 2,119,534
Capital and reserves
Called up share capital 10 10
Profit and loss account 2,357,273 2,119,524
Shareholder's funds 2,357,283 2,119,534
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Tahl Holtzman
Director
Approved by the board on 25 October 2025
Cambridge Neurotech Limited
Notes to the Accounts
for the year ended 30 November 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery at 25.00% straight line
Computer equipment at 33.33% straight line
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 2 2
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 December 2023 26,735
Additions 3,172
At 30 November 2024 29,907
Depreciation
At 1 December 2023 15,665
Charge for the year 6,547
At 30 November 2024 22,212
Net book value
At 30 November 2024 7,695
At 30 November 2023 11,070
4 Debtors 2024 2023
£ £
Trade debtors 194,047 248,912
Other debtors 563,023 558,594
757,070 807,506
5 Investments held as current assets 2024 2023
£ £
Fair value
Listed investments 248,998 -
6 Creditors: amounts falling due within one year 2024 2023
£ £
Trade creditors 18,032 102,766
Taxation and social security costs 91,644 122,743
Other creditors 10,494 5,620
120,170 231,129
7 Loans to directors
Description and conditions B/fwd Paid Repaid C/fwd
£ £ £ £
Dr Tahl Holtzman 401,438 224,946 (226,477) 399,907
Sarah-Jane McEwan 157,156 20,000 (22,157) 154,999
Interest has been charged at the official HMRC rate.
558,594 20,000 (248,634) 554,906
8 Related party transactions
The directors' emoluments for the year was £264,934 (2023: £142,294).
9 Other information
Cambridge Neurotech Limited is a private company limited by shares and incorporated in England. Its registered office is:
64 High Street
Swaffham Prior
Cambridge
Cambridgeshire
CB25 0LD
Cambridge Neurotech Limited 08783030 false 2023-12-01 2024-11-30 2024-11-30 VT Final Accounts April 2024 Dr Tahl Holtzman No description of principal activity 08783030 2022-12-01 2023-11-30 08783030 core:WithinOneYear 2023-11-30 08783030 core:ShareCapital 2023-11-30 08783030 core:RetainedEarningsAccumulatedLosses 2023-11-30 08783030 2023-12-01 2024-11-30 08783030 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 08783030 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 08783030 bus:Director40 2023-12-01 2024-11-30 08783030 1 2023-12-01 2024-11-30 08783030 2 2023-12-01 2024-11-30 08783030 core:PlantMachinery 2023-12-01 2024-11-30 08783030 bus:Director1 2023-12-01 2024-11-30 08783030 countries:England 2023-12-01 2024-11-30 08783030 bus:FRS102 2023-12-01 2024-11-30 08783030 bus:FilletedAccounts 2023-12-01 2024-11-30 08783030 2024-11-30 08783030 core:WithinOneYear 2024-11-30 08783030 core:ShareCapital 2024-11-30 08783030 core:RetainedEarningsAccumulatedLosses 2024-11-30 08783030 core:PlantMachinery 2024-11-30 08783030 2023-11-30 08783030 core:PlantMachinery 2023-11-30 iso4217:GBP xbrli:pure